| 2025年中报 | 2024年年报 | 2024年中报 | 2023年年报 | 2023年中报 | |
|---|---|---|---|---|---|
| 营业收入(元) | |||||
| 检测收入(元) | 12,848,695.66 | 44,685,695.97 | 15,813,362.77 | 82,669,842.72 | 60,911,932.24 |
| 试剂收入(元) | 73,799,001.72 | 200,979,449.44 | 107,751,145.62 | 217,816,060.39 | 101,150,602.06 |
| 维保收入(元) | 1,042,149.67 | 1,742,586.65 | 798,496.57 | 2,937,977.70 | 565,012.34 |
| 仪器收入(元) | 29,020,811.35 | 93,687,433.27 | 12,104,064.98 | 35,224,089.79 | 18,050,305.59 |
| 营业成本(元) | |||||
| 检测收入(元) | 7,110,377.08 | 18,385,946.41 | 6,841,032.85 | 35,705,652.05 | 26,300,131.14 |
| 试剂收入(元) | 50,073,012.92 | 141,070,073.84 | 71,827,581.38 | 150,357,387.20 | 65,968,384.53 |
| 维保收入(元) | 736,136.66 | 1,361,165.84 | 560,408.20 | 2,119,857.60 | 342,701.46 |
| 仪器收入(元) | 28,839,579.04 | 87,403,673.82 | 12,040,924.71 | 31,314,494.08 | 17,950,083.21 |
| 毛利(元) | |||||
| 检测收入(元) | 5,738,318.58 | 26,299,749.56 | 8,972,329.92 | 46,964,190.67 | 34,611,801.10 |
| 试剂收入(元) | 23,725,988.80 | 59,909,375.60 | 35,923,564.24 | 67,458,673.19 | 35,182,217.53 |
| 维保收入(元) | 306,013.01 | 381,420.81 | 238,088.37 | 818,120.10 | 222,310.88 |
| 仪器收入(元) | 181,232.31 | 6,283,759.45 | 63,140.27 | 3,909,595.71 | 100,222.38 |
| 毛利率(%) | |||||
| 检测收入(%) | 44.66 | 58.85 | 56.74 | 56.81 | 56.82 |
| 试剂收入(%) | 32.15 | 29.81 | 33.34 | 30.97 | 34.78 |
| 维保收入(%) | 29.36 | 21.89 | 29.82 | 27.85 | 39.35 |
| 仪器收入(%) | 0.62 | 6.71 | 0.52 | 11.10 | 0.56 |
| 收入构成(%) | |||||
| 检测收入(%) | 11.01 | 13.10 | 11.59 | 24.41 | 33.71 |
| 试剂收入(%) | 63.23 | 58.92 | 78.96 | 64.32 | 55.98 |
| 维保收入(%) | 0.89 | 0.51 | 0.59 | 0.87 | 0.31 |
| 仪器收入(%) | 24.87 | 27.47 | 8.87 | 10.40 | 9.99 |
| 毛利构成(%) | |||||
| 检测收入(%) | 19.16 | 28.32 | 19.85 | 39.42 | 49.36 |
| 试剂收入(%) | 79.21 | 64.51 | 79.48 | 56.62 | 50.18 |
| 维保收入(%) | 1.02 | 0.41 | 0.53 | 0.69 | 0.32 |
| 仪器收入(%) | 0.61 | 6.77 | 0.14 | 3.28 | 0.14 |